• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度的 SARS-CoV-2 感染与趋势不符:训练有素的先天免疫?

SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?

机构信息

Infectious Disease Genetics, National Institute of Biomedical Genomics, Kalyani, India.

出版信息

Am J Hum Biol. 2021 Nov;33(6):e23504. doi: 10.1002/ajhb.23504. Epub 2020 Sep 23.

DOI:10.1002/ajhb.23504
PMID:32965717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7536963/
Abstract

SARS-CoV-2, the causative agent of COVID-19 pandemic caught the world unawares by its sudden onset in early 2020. Memories of the 1918 Spanish Flu were rekindled raising extreme fear for the virus, but in essence, it was the host and not the virus, which was deciding the outcome of the infection. Age, gender, and preexisting conditions played critical roles in shaping COVID-19 outcome. People of lower socioeconomic strata were disproportionately affected in industrialized countries such as the United States. India, a developing country with more than 1.3 billion population, a large proportion of it being underprivileged and with substandard public health provider infrastructure, feared for the worst outcome given the sheer size and density of its population. Six months into the pandemic, a comparison of COVID-19 morbidity and mortality data between India, the United States, and several European countries, reveal interesting trends. While most developed countries show curves expected for a fast-spreading respiratory virus, India seems to have a slower trajectory. As a consequence, India may have gained on two fronts: the spread of the infection is unusually prolonged, thus leading to a curve that is "naturally flattened"; concomitantly the mortality rate, which is a reflection of the severity of the disease has been relatively low. I hypothesize that trained innate immunity, a new concept in immunology, may be the phenomenon behind this. Biocultural, socioecological, and socioeconomic determinants seem to be influencing the outcome of COVID-19 in different regions/countries of the world.

摘要

SARS-CoV-2,即导致 COVID-19 大流行的病原体,于 2020 年初突然爆发,令全世界猝不及防。人们回想起 1918 年的西班牙流感,由此产生了对该病毒的极度恐惧,但实际上,决定感染结果的是宿主,而不是病毒。年龄、性别和既往疾病在塑造 COVID-19 结局方面起着关键作用。在像美国这样的工业化国家中,社会经济地位较低的人群受到了不成比例的影响。印度是一个拥有超过 13 亿人口的发展中国家,其中很大一部分人处于贫困状态,公共卫生服务基础设施也不达标,因此人们对其庞大的人口规模和人口密度感到担忧,害怕出现最坏的结果。在大流行六个月后,对印度、美国和几个欧洲国家 COVID-19 发病率和死亡率数据进行比较,揭示了一些有趣的趋势。虽然大多数发达国家的曲线都符合快速传播的呼吸道病毒的预期,但印度的曲线似乎较为平缓。因此,印度可能在两个方面取得了进展:感染的传播异常延长,从而导致曲线“自然变平”;同时,死亡率,即疾病严重程度的反映,相对较低。我假设,经过训练的先天免疫,这是免疫学中的一个新概念,可能是造成这种情况的原因。生物文化、社会生态和社会经济决定因素似乎在影响着全球不同地区/国家 COVID-19 的结局。

相似文献

1
SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?印度的 SARS-CoV-2 感染与趋势不符:训练有素的先天免疫?
Am J Hum Biol. 2021 Nov;33(6):e23504. doi: 10.1002/ajhb.23504. Epub 2020 Sep 23.
2
Understanding the devastating second wave of COVID-19 pandemic in India.了解印度第二波毁灭性的新冠疫情。
Am J Hum Biol. 2021 Nov;33(6):e23671. doi: 10.1002/ajhb.23671. Epub 2021 Sep 1.
3
A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.印度 COVID-19 大流行期间对冠状病毒病、疫苗接种和相关研究的公众知识和观点的横断面调查。
J Assoc Physicians India. 2023 Sep;71(9):19-27. doi: 10.59556/japi.71.0335.
4
SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.SARS-CoV-2 大流行与建筑行业:来自意大利数据的洞察。
Acta Biomed. 2022 Jul 1;93(3):e2022233. doi: 10.23750/abm.v93i3.12265.
5
COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection?发展中国家的 COVID-19:α-半乳糖的免疫反应是否是减轻感染严重程度的一个被忽视的因素?
ACS Infect Dis. 2020 Dec 11;6(12):3104-3108. doi: 10.1021/acsinfecdis.0c00747. Epub 2020 Nov 12.
6
India's Response to the COVID-19 Pandemic: A Frontal Assault on the "Historically Dispossessed".印度对 COVID-19 大流行的应对:对“历史上被剥夺权利者”的正面攻击。
Int J Health Serv. 2021 Jan;51(1):107-114. doi: 10.1177/0020731420968438. Epub 2020 Oct 22.
7
Geographic information system-based analysis of COVID-19 cases in India during pre-lockdown, lockdown, and unlock phases.基于地理信息系统对印度在封锁前、封锁期间及解封阶段新冠病毒疾病病例的分析。
Int J Infect Dis. 2021 Apr;105:424-435. doi: 10.1016/j.ijid.2021.02.070. Epub 2021 Feb 18.
8
Epidemic Landscape and Forecasting of SARS-CoV-2 in India.印度 SARS-CoV-2 的疫情形势和预测。
J Epidemiol Glob Health. 2021 Mar;11(1):55-59. doi: 10.2991/jegh.k.200823.001. Epub 2020 Aug 28.
9
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
10
SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.东亚和太平洋地区的 SARS-CoV-2 第二波监测:纵向趋势分析。
J Med Internet Res. 2021 Feb 1;23(2):e25454. doi: 10.2196/25454.

引用本文的文献

1
BCG immunization mitigates SARS-CoV-2 replication in macaques via monocyte efferocytosis and neutrophil recruitment in lungs.卡介苗免疫通过单核细胞胞葬作用和肺部中性粒细胞募集减轻猕猴体内的新冠病毒复制。
JCI Insight. 2025 Aug 8;10(15). doi: 10.1172/jci.insight.194633.
2
An after-action review of COVID-19 cases and mitigation measures at US Mission India, March 2020-July 2021.2020年3月至2021年7月美国驻印度使团新冠疫情病例及缓解措施的事后分析。
PLOS Glob Public Health. 2025 May 20;5(5):e0003982. doi: 10.1371/journal.pgph.0003982. eCollection 2025.
3
Editorial: Vaccine-induced innate immunity and its role in viral infections.社论:疫苗诱导的先天免疫及其在病毒感染中的作用。
Front Immunol. 2024 Jul 11;15:1440061. doi: 10.3389/fimmu.2024.1440061. eCollection 2024.
4
COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbionts.低收入人群与高收入人群中新冠病毒感染率的差异凸显了恢复真核共生生物已丧失生物多样性的必要性。
iScience. 2023 Mar 17;26(3):106167. doi: 10.1016/j.isci.2023.106167. Epub 2023 Feb 9.
5
Sero-epidemiological survey of SARS-Cov2 in urban slums of a capital city: A cross- sectional study.首都城市贫民窟中新冠病毒的血清流行病学调查:一项横断面研究。
J Family Med Prim Care. 2022 Jun;11(6):2709-2716. doi: 10.4103/jfmpc.jfmpc_2127_21. Epub 2022 Jun 30.
6
SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)/COVID-19 及其与核苷酸结合寡聚化结构域 2(NOD2)和泛素化的关系。
Clin Immunol. 2022 May;238:109027. doi: 10.1016/j.clim.2022.109027. Epub 2022 May 2.
7
Comparative Analysis of Susceptibility and Severity of COVID-19 in Countries from the Eastern and the Western World Till March '21.截至2021年3月,东西方国家新冠病毒病易感性和严重程度的比较分析
Microbiol Insights. 2021 Aug 30;14:11786361211041367. doi: 10.1177/11786361211041367. eCollection 2021.
8
Understanding the devastating second wave of COVID-19 pandemic in India.了解印度第二波毁灭性的新冠疫情。
Am J Hum Biol. 2021 Nov;33(6):e23671. doi: 10.1002/ajhb.23671. Epub 2021 Sep 1.
9
Between a hygiene rock and a hygienic hard place: Avoiding SARS-CoV-2 while needing environmental exposures for immunity.处于卫生困境之中:在需要接触环境以获得免疫力的同时避免感染新冠病毒。
Evol Med Public Health. 2021 Feb 12;9(1):120-130. doi: 10.1093/emph/eoab006. eCollection 2021.
10
COVID-19 pandemic and breast cancer management: A retrospective observational clinical study from Pakistan.2019冠状病毒病大流行与乳腺癌管理:一项来自巴基斯坦的回顾性观察性临床研究。
Ann Med Surg (Lond). 2021 Mar;63:102151. doi: 10.1016/j.amsu.2021.01.099. Epub 2021 Feb 4.

本文引用的文献

1
Social determinants of COVID-19 mortality at the county level.县级层面下 COVID-19 死亡率的社会决定因素。
PLoS One. 2020 Oct 14;15(10):e0240151. doi: 10.1371/journal.pone.0240151. eCollection 2020.
2
Why COVID-19 models should incorporate the network of social interactions.为什么 COVID-19 模型应该纳入社交互动网络。
Phys Biol. 2020 Oct 13;17(6):065008. doi: 10.1088/1478-3975/aba8ec.
3
Doing biocultural anthropology: Continuity and change.做生物文化人类学:延续与变迁。
Am J Hum Biol. 2020 Jul;32(4):e23471. doi: 10.1002/ajhb.23471. Epub 2020 Jul 18.
4
Don't blame the BAME: Ethnic and structural inequalities in susceptibilities to COVID-19.不要指责少数族裔:新冠病毒易感性方面的种族和结构性不平等
Am J Hum Biol. 2020 Sep;32(5):e23478. doi: 10.1002/ajhb.23478. Epub 2020 Jul 16.
5
Forecasting efforts from prior epidemics and COVID-19 predictions.预测以往疫情和 COVID-19 的努力。
Eur J Epidemiol. 2020 Aug;35(8):727-729. doi: 10.1007/s10654-020-00661-0. Epub 2020 Jul 17.
6
Does the hygiene hypothesis apply to COVID-19 susceptibility?卫生假说是否适用于 COVID-19 的易感性?
Microbes Infect. 2020 Oct;22(9):400-402. doi: 10.1016/j.micinf.2020.07.002. Epub 2020 Jul 9.
7
Extrapulmonary manifestations of COVID-19.COVID-19 的肺外表现。
Nat Med. 2020 Jul;26(7):1017-1032. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10.
8
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).BCG 疫苗可预防严重的 2019 年冠状病毒病(COVID-19)。
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726. doi: 10.1073/pnas.2008410117. Epub 2020 Jul 9.
9
Bacillus Calmette-Guérin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study.美国罗德岛州卡介苗接种与 COVID-19 的临床特征和结局:一项队列研究。
Epidemiol Infect. 2020 Jul 9;148:e140. doi: 10.1017/S0950268820001569.
10
Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.新冠疫情:西班牙报告血清阳性率为5%后,专家称群体免疫“不道德且无法实现”。
BMJ. 2020 Jul 7;370:m2728. doi: 10.1136/bmj.m2728.